The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 04, 2023

Filed:

Aug. 29, 2019
Applicant:

Curevac SE, Tübingen, DE;

Inventors:

Patrick Baumhof, Dusslingen, DE;

Thomas Kramps, Tübingen, DE;

Söhnke Voss, Neckargemund, DE;

Karl-Josef Kallen, Konigsdorf, DE;

Mariola Fotin-Mleczek, Sindelfingen, DE;

Assignee:

CureVac SE, Tübingen, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/385 (2006.01); A61K 39/39 (2006.01); A61K 39/12 (2006.01); A61K 39/00 (2006.01); A61K 47/64 (2017.01); A61K 39/145 (2006.01); A61K 39/205 (2006.01); A61K 39/29 (2006.01); A61K 39/35 (2006.01); A61K 48/00 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 39/0011 (2013.01); A61K 39/00117 (2018.08); A61K 39/001104 (2018.08); A61K 39/001106 (2018.08); A61K 39/001109 (2018.08); A61K 39/001135 (2018.08); A61K 39/001151 (2018.08); A61K 39/001153 (2018.08); A61K 39/001156 (2018.08); A61K 39/001157 (2018.08); A61K 39/001164 (2018.08); A61K 39/001168 (2018.08); A61K 39/001182 (2018.08); A61K 39/001186 (2018.08); A61K 39/001188 (2018.08); A61K 39/001191 (2018.08); A61K 39/001192 (2018.08); A61K 39/001193 (2018.08); A61K 39/001194 (2018.08); A61K 39/001195 (2018.08); A61K 39/12 (2013.01); A61K 39/145 (2013.01); A61K 39/205 (2013.01); A61K 39/29 (2013.01); A61K 39/35 (2013.01); A61K 47/645 (2017.08); A61K 47/646 (2017.08); A61K 48/0041 (2013.01); C12N 7/00 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/53 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/572 (2013.01); A61K 2039/575 (2013.01); A61K 2039/6093 (2013.01); C12N 2710/20034 (2013.01); C12N 2710/20071 (2013.01); C12N 2730/10134 (2013.01); C12N 2730/10171 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/16171 (2013.01); C12N 2760/20134 (2013.01); C12N 2760/20171 (2013.01); Y02A 50/30 (2018.01);
Abstract

The present invention is directed to a pharmaceutical composition including (e.g. for use as an adjuvant) a polymeric carrier cargo complex, comprising as a carrier a polymeric carrier formed by disulfide-crosslinked cationic components; and as a cargo at least one nucleic acid molecule, and at least one antigen that is selected from an antigen from a pathogen associated with infectious disease; an antigen associated with allergy or allergic disease; an antigen associated with autoimmune disease; or an antigen associated with a cancer or tumour disease, or in each case a fragment, variant and/or derivative of said antigen. The pharmaceutical composition allows for efficient induction of an adaptive immune response directed against said antigen. The present invention furthermore provides kits, as well as the use of the pharmaceutical composition or the kit as a vaccine, particularly in the treatment of infectious diseases, allergies, autoimmune diseases and tumour or cancer diseases.


Find Patent Forward Citations

Loading…